Saliva-Based Screening Market Set for 7.9% CAGR Growth Through 2033, Driven by Innovation and Demand

The global saliva-based screening market is experiencing significant growth, driven by its ability to provide non-invasive, cost-effective, and reliable diagnostic solutions. As of 2022, the market was valued at USD 320.6 million and is expected to expand at a robust compound annual growth rate (CAGR) of 7.9% through 2033, reaching a projected value of USD 738.5 million by the end of the forecast period. This growth is fueled by the increasing demand for non-invasive diagnostic methods, particularly in the fields of infectious disease detection and genetic testing.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/32714

Saliva-based screening has become a preferred choice for many due to its ease of use and the rising awareness of its benefits. Compared to traditional blood-based tests, saliva-based tests offer a less invasive, more comfortable method for collecting samples. The market is being driven by advancements in technology, increased public health awareness, and the growing prevalence of diseases that can be diagnosed through saliva tests. Furthermore, the market's expansion is further supported by innovations in testing kits, regulatory approvals, and the adoption of saliva-based testing in various healthcare settings worldwide.

Key Highlights from the Report

✦ The global saliva-based screening market size was valued at USD 320.6 million in 2022.

✦ The market is expected to grow at a CAGR of 7.9% from 2023 to 2033, reaching a projected value of USD 738.5 million by 2033.

✦ Saliva-based detection kits are expected to hold the largest market share of approximately 60.2% in 2023.

✦ North America, particularly the U.S., is projected to dominate the market, accounting for nearly 28.9% of the market share in 2023.

✦ The diagnostic application segment is estimated to capture a significant market share of 77.5% in 2023.

✦ Hospitals and clinics are expected to remain the dominant end-users, with an estimated market share of 49.6% in 2023.

Market Segmentation

The saliva-based screening market is segmented across various categories, including product types, applications, end-users, and geographical regions.

Product Type:

Saliva-based Detection Kits: This segment is expected to hold the largest market share, driven by the widespread use of saliva-based kits for detecting diseases such as COVID-19. The rise in demand for rapid testing and at-home testing solutions has further fueled the growth of this segment.

Diagnostic Tools and Devices: The diagnostic tools segment, particularly those related to molecular diagnostics and infectious disease testing, is also growing. These tools offer reliable and efficient testing methods, which enhance their adoption in hospitals and clinics.

Application:

Infection Detection/Analysis: This is one of the largest applications of saliva-based screening, with an emphasis on detecting infectious diseases such as COVID-19, flu, and other respiratory infections.

Genetic and Molecular Testing: Saliva samples are increasingly being used for genetic testing, particularly in detecting inherited diseases and conditions.

Drug Testing: Saliva is also widely used for drug testing, particularly for substances that can be detected in oral fluid.

End-User:

Hospitals & Clinics: This segment is expected to dominate the market, driven by the increasing adoption of saliva-based tests in clinical settings. The convenience and ease of use offered by these tests make them an ideal choice for healthcare providers.

Homecare & Self-Testing: The rise of homecare kits, particularly for infectious disease testing, is expected to increase in the coming years. This segment's growth is largely driven by consumer demand for easy-to-use, non-invasive testing solutions that can be performed at home.

Regional Insights

The global saliva-based screening market is characterized by diverse regional dynamics, with North America, Europe, and Asia Pacific emerging as key markets.

North America: The U.S. is expected to hold the largest market share, accounting for nearly 28.9% of the global market in 2023. The U.S. has seen rapid adoption of saliva-based testing, particularly in response to the COVID-19 pandemic. The increasing demand for self-testing kits and the growing awareness of the benefits of non-invasive testing contribute to the region's dominance. Additionally, the presence of major players and ongoing innovations in saliva-based testing further bolster market growth.

Europe: Germany is one of the prominent markets for saliva-based screening in Europe, with an anticipated market share of 10% in 2023. The European Medicines Agency (EMA) has approved several major products for sale in Germany, contributing to the region's growth. The rise in public health initiatives and the increasing demand for early disease detection are key drivers in Europe.

Asia Pacific: India is expected to experience significant growth in the saliva-based screening market, driven by increasing public health awareness and government initiatives promoting early disease detection. The Indian market is forecast to grow at a CAGR of 8.5% from 2023 to 2033, accounting for more than 73% of the South Asian market in 2023.

Market Drivers

Several factors are contributing to the robust growth of the saliva-based screening market. Key drivers include the increasing preference for non-invasive diagnostic tests, advancements in technology, and the growing demand for rapid disease detection. The rising prevalence of infectious diseases, such as COVID-19, and the convenience of using saliva for testing are also significant contributors. Additionally, the ability to perform saliva-based tests at home has gained traction due to its ease of use and minimal discomfort, further driving market expansion.

Innovative products and regulatory approvals for saliva-based diagnostic kits are accelerating the growth of the market. For instance, companies like Chembio Diagnostics and Nalagenetics have introduced FDA-approved saliva-based test kits for COVID-19 detection, capitalizing on the increasing demand for reliable, quick testing solutions.

Market Restraints

Despite its growth potential, the saliva-based screening market faces several challenges. One major restraint is the competition from other specimen types, such as blood and nasal swabs, which have been traditionally used for diagnostic testing. The emergence of new testing kits based on nasal swabs has limited the widespread adoption of saliva-based tests in some regions.

Additionally, there is a lack of sufficient infrastructure and expertise in some regions to conduct saliva-based testing. Diagnostic facilities in rural or underserved areas may not have the necessary equipment or training to perform accurate saliva tests. Furthermore, the availability of subpar testing kits from emerging manufacturers poses a risk to the market's overall quality and reliability.

Market Opportunities

The growing demand for early disease detection presents significant opportunities for the saliva-based screening market. As advancements in genetic research continue, there will be an increasing focus on using saliva for genetic and molecular testing. The increasing preference for self-testing kits and the convenience of home-based diagnostic solutions further open new avenues for market growth.

Additionally, the expansion of government and non-government health initiatives in emerging markets like India and other parts of Asia offers vast opportunities for market expansion. The increasing emphasis on preventative healthcare and early disease detection will likely drive demand for non-invasive diagnostic tests like saliva-based screening.

Frequently Asked Questions (FAQs)

How Big is the Saliva-based Screening Market?
Who are the Key Players in the Global Saliva-based Screening Market?
What is the Projected Growth Rate of the Saliva-based Screening Market?
What is the Market Forecast for Saliva-based Screening in 2033?
Which Region is Estimated to Dominate the Saliva-based Screening Industry through the Forecast Period?

Company Insights

• Chembio Diagnostics, Inc.: A leading player in the market known for its saliva-based rapid diagnostic kits.

• Good Start Genetics: Developers of saliva-based screening tests for genetic disorders.

• Nalagenetics: Known for their PCR-based saliva testing kits for COVID-19 detection.

• Nusantics: Another key player that has gained regulatory approval for their saliva-based diagnostic kits.

Recent Developments:

In April 2021, Chembio Diagnostics, Inc. launched a rapid point-of-care test for COVID-19 and Flu A&B that received approval from the U.S. FDA.

Nalagenetics and Nusantics received regulatory approval for PCR-based saliva testing kits for COVID-19 detection, offering an alternative to swab-based tests.

Conclusion

The saliva-based screening market is poised for remarkable growth in the coming years, driven by technological advancements, rising consumer demand for non-invasive diagnostics, and increasing awareness about the benefits of saliva testing. The market presents numerous opportunities, particularly in regions like North America, Europe, and Asia Pacific, where technological adoption is accelerating. However, challenges such as competition from other testing methods and infrastructure limitations in certain regions must be addressed for the market to realize its full potential. As the market continues to evolve, saliva-based screening will play a crucial role in the early detection of diseases, driving further innovation in the healthcare industry.

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.